Epigallocatechin-3-gallate inhibits osteopontin expression and prevents experimentally induced hepatic fibrosis
- PMID: 35594711
- DOI: 10.1016/j.biopha.2022.113111
Epigallocatechin-3-gallate inhibits osteopontin expression and prevents experimentally induced hepatic fibrosis
Abstract
Osteopontin (OPN) is a matricellular cytokine and a stress-induced profibrogenic molecule that promotes activation of stellate cells during the pathogenesis of hepatic fibrosis. We studied the protective effects of epigallocatechin-3-gallate (EGCG) to suppress oxidative stress, inhibit OPN expression, and prevent experimentally induced hepatic fibrosis. Liver injury was induced with intraperitoneal injections of N-nitrosodimethylamine (NDMA) in a dose of 1 mg/100 g body weight on 3 consecutive days of a week for 28 days. A group of rats received 0.2 mg EGCG/100 g body weight orally everyday during the study. The animals were sacrificed on day 28th from the beginning of exposure. Serum levels of AST, ALT, OPN, malondialdehyde, collagen type IV, and hyaluronic acid were measured. Immunohistochemistry and/or real-time PCR were performed for α-SMA, 4-HNE, OPN, collagen type I, and type III. Serial administrations of NDMA produced well developed fibrosis and early cirrhosis in rat liver. Treatment with EGCG significantly reduced serum/plasma levels of AST, ALT, OPN, malondialdehyde, collagen type IV, and hyaluronic acid and prevented deposition of collagen fibers in the hepatic tissue. Protein and/or mRNA levels demonstrated marked decrease in the expression of α-SMA, 4-HNE, OPN, collagen type I, and type III. Treatment with EGCG prevented excessive generation of reactive oxygen species, suppressed oxidative stress, significantly reduced serum and hepatic OPN levels, and markedly attenuated hepatic fibrosis. The results indicated that EGCG could be used as a potent therapeutic agent to prevent hepatic fibrogenesis and related adverse events.
Keywords: 4-hydroxy-2-nonenal; Epigallocatechin-3-gallate; Hepatic fibrosis; N-Nitrosodimethylamine; Osteopontin.
Copyright © 2022. Published by Elsevier Masson SAS.
Similar articles
-
Osteopontin - A potential biomarker of advanced liver disease.Ann Hepatol. 2020 Jul-Aug;19(4):344-352. doi: 10.1016/j.aohep.2020.01.001. Epub 2020 Jan 17. Ann Hepatol. 2020. PMID: 32005637 Review.
-
Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis.Cell Death Dis. 2019 Jan 8;10(1):18. doi: 10.1038/s41419-018-1272-8. Cell Death Dis. 2019. PMID: 30622238 Free PMC article. Review.
-
MMP-13 deletion decreases profibrogenic molecules and attenuates N-nitrosodimethylamine-induced liver injury and fibrosis in mice.J Cell Mol Med. 2017 Dec;21(12):3821-3835. doi: 10.1111/jcmm.13304. Epub 2017 Aug 7. J Cell Mol Med. 2017. PMID: 28782260 Free PMC article.
-
Epigallocatechin-3-Gallate Upregulates miR-221 to Inhibit Osteopontin-Dependent Hepatic Fibrosis.PLoS One. 2016 Dec 9;11(12):e0167435. doi: 10.1371/journal.pone.0167435. eCollection 2016. PLoS One. 2016. PMID: 27935974 Free PMC article.
-
Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.Hepatology. 2012 Feb;55(2):594-608. doi: 10.1002/hep.24701. Hepatology. 2012. PMID: 21953216 Free PMC article.
Cited by
-
Potential of Plant-Derived Compounds in Preventing and Reversing Organ Fibrosis and the Underlying Mechanisms.Cells. 2024 Feb 28;13(5):421. doi: 10.3390/cells13050421. Cells. 2024. PMID: 38474385 Free PMC article. Review.
-
The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy.Front Immunol. 2024 Jan 29;15:1331641. doi: 10.3389/fimmu.2024.1331641. eCollection 2024. Front Immunol. 2024. PMID: 38348027 Free PMC article. Review.
-
Catechins: Protective mechanism of antioxidant stress in atherosclerosis.Front Pharmacol. 2023 Mar 24;14:1144878. doi: 10.3389/fphar.2023.1144878. eCollection 2023. Front Pharmacol. 2023. PMID: 37033663 Free PMC article. Review.
-
Surgical implantation of human adipose derived stem cells attenuates experimentally induced hepatic fibrosis in rats.Mol Med. 2022 Nov 29;28(1):143. doi: 10.1186/s10020-022-00566-6. Mol Med. 2022. PMID: 36447136 Free PMC article.
-
Metabolomic analysis reveals dynamic changes in secondary metabolites of Sophora japonica L. during flower maturation.Front Plant Sci. 2022 Aug 4;13:916410. doi: 10.3389/fpls.2022.916410. eCollection 2022. Front Plant Sci. 2022. PMID: 35991425 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials